Frequency of New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients: Insights from A Hospital-Based Cross-Sectional Study
DOI:
https://doi.org/10.37762/jgmds.12-4.771Keywords:
Chronic obstructive pulmonary disease, Atrial fibrillation, Frequency, Risk factor, HospitalizationAbstract
OBJECTIVES
This study aimed to determine the frequency of new-onset atrial fibrillation (AF) in patients with chronic obstructive pulmonary disease (COPD).
METHODOLOGY
This cross-sectional study was conducted in the Department of Medicine at Hayatabad Medical Complex, Peshawar, Pakistan, from July 20, 2023, to January 15, 2025. Patients of COPD who were in normal sinus rhythm within the three months before admission were eligible for the study. Patients with the following were excluded: Ischemic heart disease, mitral valve disease, left-sided heart failure, diabetes mellitus, hypertension, hypo- or hyperkalemia, or thyroid disorders. A total of 147 patients who met the inclusion and exclusion criteria were enrolled in the study. All study participants underwent an electrocardiogram on admission and daily until discharge to look for new-onset AF.
RESULTS
Most patients were male (74.1%, n = 109) with a median age of 60 years (IQR: 53–67) and a median duration of COPD of 5 years (IQR: 4–7). New-onset AF was identified in 22 patients (15%; 95% CI: 9–21%). Patients with AF were significantly older than those without AF (71.5 years [IQR: 63.75–75.5] versus 58 years [IQR: 52–65], p < 0.001). Likewise, patients with AF had a significantly longer duration of COPD [8 years (IQR: 6 – 9)] than those without AF [5 years (IQR: 4 – 7)] (p<0.001). There was no significant difference in the frequency of AF by gender.
CONCLUSION
Older age and higher duration of COPD are significant risk factors for the development of AF in patients with COPD. Patients with COPD need regular surveillance for the timely diagnosis of AF and subsequent risk stratification to guide optimal management.
Downloads
Metrics
References
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59. https://doi.org/10.1016/j.eclinm.2023.101936. PMID: 37436316 DOI: https://doi.org/10.1016/j.eclinm.2023.101936
World Health Organization. Chronic obstructive pulmonary disease (COPD). 2024. Accessed July 29, 2025. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58. https://doi.org/10.1016/S2213-2600(21)00511-7. PMID: 35279289 DOI: https://doi.org/10.1016/S2213-2600(21)00511-7
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0. PMID: 34487721 DOI: https://doi.org/10.1016/S1474-4422(21)00252-0
Grymonprez M, Vakaet V, Kavousi M, Stricker BH, Ikram MA, Heeringa J, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118-24. https://doi.org/10.1016/j.ijcard.2018.09.056. PMID: 30268604 DOI: https://doi.org/10.1016/j.ijcard.2018.09.056
Frederiksen TC, Dahm CC, Preis SR, Lin H, Trinquart L, Benjamin EJ, et al. The bidirectional association between atrial fibrillation and myocardial infarction. Nat Rev Cardiol. 2023;20(9):631-44. https://doi.org/10.1038/s41569-023-00857-3. PMID: 37369482 DOI: https://doi.org/10.1038/s41569-023-00857-3
Huang T, Huang X, Cui X, Dong Q. Predictive nomogram models for atrial fibrillation in COPD patients: a comprehensive analysis of risk factors and prognosis. Exp Ther Med. 2024;27(4):171. https://doi.org/10.3892/etm.2024.12459. PMID: 38619258 DOI: https://doi.org/10.3892/etm.2024.12459
Liu CC, Chen YH, Chang YH, Chien WC, Lin HC, Cheng CG, et al. New-onset atrial fibrillation is a risk factor of ischemic stroke in chronic obstructive pulmonary disease. Healthcare (Basel). 2022;10(2):381. https://doi.org/10.3390/healthcare10020381. PMID: 35270467 DOI: https://doi.org/10.3390/healthcare10020381
Ye J, Yao P, Shi X, Yu X. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome. Heart Lung. 2022;51:67–74. https://doi.org/10.1016/j.hrtlng.2021.09.001. PMID: 34687836 DOI: https://doi.org/10.1016/j.hrtlng.2021.09.001
Nadeem R, Sharieff A, Tanna S, Sidhu H, Molnar J, Nadeem A. Potential augmentation of the risk of ischemic cerebrovascular accident by chronic obstructive pulmonary disease in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2015;24(8):1893–6. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.034. PMID: 26117013 DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.034
Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J. 2021;42(5):532–40. https://doi.org/10.1093/eurheartj/ehaa822. PMID: 33170970 DOI: https://doi.org/10.1093/eurheartj/ehaa822
Shabbir A, Hussain Zaidi SB, Nisar S. Frequency of ECG abnormalities in patients of chronic obstructive pulmonary disease according to disease severity. Pak Armed Forces Med J. 2017;67(4):569–74
Agustí A, Beasley R, Celli B, et al. Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals. Global Initiative for Chronic Obstructive Lung Disease, Inc. 2019
Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–156. https://doi.org/10.1161/CIR.0000000000001193. PMID: 38033089 DOI: https://doi.org/10.1161/CIR.0000000000001218
Kotlyarov S, Lyubavin A. Early detection of atrial fibrillation in chronic obstructive pulmonary disease patients. Medicina (Kaunas). 2024;60(3):352. https://doi.org/10.3390/medicina60030352. PMID: 38542439 DOI: https://doi.org/10.3390/medicina60030352
Huang B, Yang Y, Zhu J, Liang Y, Zhang H, Tian L, et al. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. J Am Med Dir Assoc. 2014;15(8):576-81. https://doi.org/10.1016/j.jamda.2014.04.009. PMID: 24835953 DOI: https://doi.org/10.1016/j.jamda.2014.04.009
Chen X, Lin M, Wang W. The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis. Oncotarget. 2017;8(60):102420–7. https://doi.org/10.18632/oncotarget.22092. PMID: 29207601 DOI: https://doi.org/10.18632/oncotarget.22092
Huang Q, Xiong H, Shuai T, Zhang M, Zhang C, Wang Y, et al. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Peer J. 2020;8. https://doi.org/10.7717/peerj.10376. PMID: 33354391 DOI: https://doi.org/10.7717/peerj.10376
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sobia Ahmed Qureshi; Fawad Rahim, Muhammad Ahmed Yar, Ayesha Bangash, Sheema Tariq, Ayesha Hamid
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
